Wells Fargo & Company Novo Nordisk A S Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Novo Nordisk A S stock. As of the latest transaction made, Wells Fargo & Company holds 4,068,854 shares of NVO stock, worth $442 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
4,068,854
Previous 4,086,556 0.43%
Holding current value
$442 Million
Previous $583 Million 16.94%
% of portfolio
0.11%
Previous 0.14%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$119.07 - $145.42 $2.11 Million - $2.57 Million
-17,702 Reduced 0.43%
4,068,854 $484 Million
Q2 2024

Aug 13, 2024
BUY
$122.71 - $146.91 $16.3 Million - $19.5 Million
132,556 Added 3.35%
4,086,556 $583 Million
Q1 2024

May 10, 2024
BUY
$102.11 - $135.92 $15.8 Million - $21 Million
154,751 Added 4.07%
3,954,000 $508 Million
Q4 2023

Feb 09, 2024
BUY
$87.78 - $105.45 $10.8 Million - $12.9 Million
122,484 Added 3.33%
3,799,249 $393 Million
Q3 2023

Nov 13, 2023
BUY
$90.94 - $199.54 $182 Million - $400 Million
2,006,189 Added 120.09%
3,676,765 $334 Million
Q2 2023

Aug 15, 2023
BUY
$155.98 - $172.65 $12.7 Million - $14.1 Million
81,545 Added 5.13%
1,670,576 $270 Million
Q1 2023

May 12, 2023
SELL
$132.34 - $159.14 $1.59 Million - $1.91 Million
-12,027 Reduced 0.75%
1,589,031 $253 Million
Q4 2022

Feb 13, 2023
SELL
$102.55 - $135.33 $243,146 - $320,867
-2,371 Reduced 0.15%
1,601,058 $217 Million
Q3 2022

Nov 14, 2022
SELL
$95.28 - $116.93 $17.5 Million - $21.5 Million
-183,887 Reduced 10.29%
1,603,429 $160 Million
Q2 2022

Aug 12, 2022
BUY
$103.24 - $121.81 $9.38 Million - $11.1 Million
90,857 Added 5.36%
1,787,316 $199 Million
Q1 2022

May 16, 2022
BUY
$93.1 - $112.54 $16.4 Million - $19.9 Million
176,527 Added 11.61%
1,696,459 $188 Million
Q4 2021

Feb 14, 2022
SELL
$95.88 - $117.08 $1.67 Million - $2.04 Million
-17,385 Reduced 1.13%
1,519,932 $170 Million
Q3 2021

Nov 15, 2021
BUY
$84.42 - $106.62 $985,772 - $1.25 Million
11,677 Added 0.77%
1,537,317 $148 Million
Q2 2021

Aug 16, 2021
SELL
$67.66 - $84.76 $15.7 Million - $19.7 Million
-232,206 Reduced 13.21%
1,525,640 $128 Million
Q1 2021

May 13, 2021
BUY
$67.06 - $75.82 $6.13 Million - $6.93 Million
91,455 Added 5.49%
1,757,846 $119 Million
Q4 2020

Feb 09, 2021
BUY
$63.89 - $73.8 $3.79 Million - $4.38 Million
59,286 Added 3.69%
1,666,391 $116 Million
Q3 2020

Nov 05, 2020
BUY
$63.69 - $70.22 $11 Million - $12.2 Million
173,193 Added 12.08%
1,607,105 $112 Million
Q2 2020

Aug 13, 2020
SELL
$58.54 - $67.94 $543,134 - $630,347
-9,278 Reduced 0.64%
1,433,912 $93.9 Million
Q1 2020

May 14, 2020
BUY
$49.46 - $64.78 $71.4 Million - $93.5 Million
1,443,190 New
1,443,190 $86.9 Million

Others Institutions Holding NVO

# of Institutions
1,955
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $245B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email